ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

With Novo Nordisk's CEO Out, Wall Street Wants an American Leader
[content-module:CompanyOverview|NYSE:NVO] Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk A/S (NYSE: NVO), Lars Fruergaard Jørgensen is on the outs. On May 16, Novo made the announcement that Jø
Announcement as on 07 June 2025

Ozempic maker Novo Nordisk ousts CEO over stock-price decline

Announcement as on 16 May 2025

Ozempic maker Novo Nordisk cuts its profit outlook

Announcement as on 07 May 2025

Novo Nordisk to phase out key drug, insulin cos spot big biz opportunity
Novo Nordisk is set to discontinue some forms of its Mixtard insulin, including pen and cartridge versions, in India, coinciding with the anticipated launch of its weight-loss drug Wegovy. This move has prompted other major insulin manufacturers like Lupin
Announcement as on 23 April 2025

Novo Nordisk to discontinue Human Mixtard, India's largest selling insulin brand
Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global strategy. They will prioritize newer, patented therapies like Ozempic and Wegovy. The company plans to introduce these therapies in
Announcement as on 22 April 2025

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 46.31
  • 12Day Average: 44.62
  • 20Day Average: 44.16
  • 50Day Average: 43.75
  • 100Day Average: 42.24
  • 150Day Average: 45.9
  • 200Day Average: 47.95

NVO Indicators & signals

Indicator MACD (12,26,9)

45.28, 44.47, 0.34
Indicator MACD is in positive zone

Indicator ADX (14)

30.67, 31.01, 16.46
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
25 Thu Jun 2026 47.63 47.13 to 48.24 0.46% 0.73 times
24 Wed Jun 2026 47.41 46.51 to 47.65 -0.02% 0.92 times
23 Tue Jun 2026 47.42 46.44 to 47.43 3.31% 1.6 times
22 Mon Jun 2026 45.90 43.87 to 46.45 6.27% 1.17 times
18 Thu Jun 2026 43.19 42.52 to 44.17 -0.76% 0.55 times
17 Wed Jun 2026 43.52 43.46 to 45.00 -0.11% 0.89 times
16 Tue Jun 2026 43.57 43.36 to 44.43 -0.8% 0.47 times
15 Mon Jun 2026 43.92 43.50 to 44.80 0.09% 0.68 times
12 Fri Jun 2026 43.88 43.72 to 44.60 -0.2% 1.34 times
11 Thu Jun 2026 43.97 42.77 to 44.11 2.71% 0.88 times
10 Wed Jun 2026 42.81 41.66 to 44.03 1.45% 1.5 times
09 Tue Jun 2026 42.20 41.06 to 42.31 2.9% 1.04 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top